The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.
Source link
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
Date:
More like thisRelated
Continental on Track to Reach Tires Guidance Despite Higher Raw Material Costs
The German tire company said it is in the...
Transfer rumors, news: Fenerbahce eye Man United’s Rashford
Fenerbahce are ready to make an ambitious move to...
Man accused of arson in the biggest of 3 major fires in Spokane, Washington
A 37-year-old Spokane, Washington, resident with a previous manslaughter...
Man from El Salvador dies in immigration jail in New Jersey
Man from El Salvador dies in immigration jail in...